Table 4 |
|||
|
Results of cost effectiveness analysis for the SHDGP Diabetes Program(a) |
|||
|
Base case |
Lower bound |
Upper bound |
|
|
|
|||
|
Cost of SHDGP Diabetes Program per patient-year (Additional file 1) |
$196 |
$146 |
$196 |
|
Treatment cost savings per patient-year (Table 3) |
-$34 |
-$116 |
+$46 |
|
Net cost per patient-year |
$162 |
$30 |
$242 |
|
Discounted net cost per patient over 40 years(b) |
$2,919 |
$540 |
$4,360 |
|
Life-years saved (Table 2) |
0.36 |
0.36 |
0.36 |
|
Increase in QALE (Table 2) |
0.30 |
0.30 |
0.30 |
|
Cost per life-year saved |
$8,108 |
$1,502 |
$12,111 |
|
Cost per year increase in QALE |
$9,730 |
$1,802 |
$14,533 |
|
|
|||
|
Note: (a) All dollar values are expressed in Australian dollars, 2005 prices. (b) Assumes net cost per patient-year is the same each year for 40 years. Discount rate = 5% per annum. Source: SHDGP Diabetes Program; UKPDS Outcomes Model [26]; [34], p.1 and Table 1; [33,35] |
|||
|
McRae et al. BMC Health Services Research 2008 8:205 doi:10.1186/1472-6963-8-205 |
|||